Nadine Benador

Dr. Nadine Benador is a distinguished Clinical Professor of Pediatrics at the Medicine University of California-San Francisco, where she has made significant strides in the field of pediatric nephrology. Her research is primarily centered on pediatric kidney disease, with a particular focus on drug-induced acute kidney injury, fluid status assessment in neonatal dialysis, and the development of core outcome domains in pediatric kidney disease. Dr. Benador has made substantial contributions to the medical community through her extensive publications. Her work on drug dosing in pediatric patients with chronic kidney disease has provided invaluable insights into optimizing therapeutic strategies for this vulnerable population. Additionally, her research on therapeutic plasma exchange for pediatric renal diseases has opened new avenues for treatment, offering hope to many young patients and their families. One of Dr. Benador's notable research interests includes the association of proteinuria with race and the underlying causes of chronic kidney disease in children. This work is crucial in understanding the disparities in kidney disease prevalence and outcomes among different racial groups, paving the way for more equitable healthcare solutions. Her investigations extend to unique pancreatic phenotypes in ciliopathies, where she explores the intricate connections between these genetic disorders and kidney function. Furthermore, Dr. Benador is actively involved in exploring the use of intraperitoneal vancomycin for treating peritonitis in children undergoing peritoneal dialysis, aiming to improve treatment efficacy and patient outcomes. Dr. Benador's dedication to advancing pediatric nephrology is evident in her commitment to research and her efforts to translate scientific findings into clinical practice. Her work continues to influence the field, driving innovation and improving the lives of children with kidney disease.